Biopharmaceuticals

The biopharmaceutical division develops, produces and markets prescription drugs for the therapeutic areas of Neurodegenerative Diseases, Oncology, Fertility, Endocrinology, CardioMetabolic Care and General Medicine.

Neurodegenerative diseases

Our goal is to offer people living with neurodegenerative diseases, such as multiple sclerosis, therapies that contribute significantly to the quality of life and meet patients’ needs.

Oncology

In oncology, we are focusing on therapeutic options that systematically target the tumor. The key is finding the right combination. This refers both to the targets of a therapy in the disease process and to the combination possibilities with standard therapies such as radiation or chemotherapy.

Fertility

For fertility treatment, we offer hormones for every stage of the reproductive cycle – from follicular development to early pregnancy.

Endocrinology

We are committed to the treatment and research of growth hormone deficiency, the rare disorder phenylketonuria (PKU) and other metabolic disorders.

CardioMetabolic Care

We offer a comprehensive range of therapeutic options for cardiovascular diseases, diabetes and thyroid diseases, thus making a significant contribution to effective treatment of often complex symptoms.

 

Biopharmaceuticals

Our biopharmaceutical business is pursuing activities in selected indications for highly specialized therapeutic areas mainly treated by specialists. The portfolio includes leading biopharmaceutical drugs that benefit patients who suffer from colorectal cancer, head and neck tumors or multiple sclerosis. In addition, we offer therapies to treat infertility, growth disorders, cardiovascular diseases, diabetes and thyroid diseases
Research and development are focused on the fields of oncology, immuno-oncology, neurodegenerative diseases, fertility, endocrinology and biosimilars.
Key products by therapeutic area
Therapeutic Area Key Products
Oncology
  • Erbitux® (solid tumors)
  • UFT®
Neurodegenerative Diseases
Fertility
Endocrinology
CardioMetabolic Care
  • Glucophage® franchise (type 2 diabetes)
  • Concor® franchise (cardiovascular diseases)
  • Euthyrox® (thyroid diseases)

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany, operate under the umbrella brand EMD.
 

DIVISION SITE

www.emdserono.com

CLINICAL TRIALS

Clinical Trials
For information on clinical trials currently being conducted in the framework of our development projects, please click here.
 
  
Read more on M - The Explorer Magazine

A bridge to the work of Arno Schmidt

Our company is building a bridge between Japan and Germany by way of the Kakehashi Literature Prize, which was presented for the first time in 2014.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Getting rid of lice easily

People with lice want to get rid of them fast. In response to customer requests, we have developed a product that makes it possible to detect lice eggs immediately.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

A weighty problem

A weighty problem: China’s dynamic economic growth has led to changes in eating habits that have caused an increase in cases of diabetes.

Read more on M - The Explorer Magazine